FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway
Inflammatory bowel disease (IBD) is a chronic idiopathic inflammatory disorder of gastro-intestinal tract, lacking effective drug targets and medications. Caffeic acid phenethyl ester (CAPE), a phenolic constituent derived from propolis, has been reported to be a potential therapeutic agent for IBD...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02969/full |
id |
doaj-786a3dae10644d77bdd04ca7007c01af |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yu Mei Yu Mei Zihao Wang Zihao Wang Yifan Zhang Yifan Zhang Ting Wan Ting Wan Jincheng Xue Jincheng Xue Wei He Wei He Yi Luo Yi Luo Yijun Xu Yijun Xu Xue Bai Qi Wang Qi Wang Yujie Huang Yujie Huang |
spellingShingle |
Yu Mei Yu Mei Zihao Wang Zihao Wang Yifan Zhang Yifan Zhang Ting Wan Ting Wan Jincheng Xue Jincheng Xue Wei He Wei He Yi Luo Yi Luo Yijun Xu Yijun Xu Xue Bai Qi Wang Qi Wang Yujie Huang Yujie Huang FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway Frontiers in Immunology inflammatory bowel disease oxidative stress nuclear factor erythroid 2-related factor (Nrf2) reactive oxygen species (ROS) caffeic acid phenethyl ester (CAPE) |
author_facet |
Yu Mei Yu Mei Zihao Wang Zihao Wang Yifan Zhang Yifan Zhang Ting Wan Ting Wan Jincheng Xue Jincheng Xue Wei He Wei He Yi Luo Yi Luo Yijun Xu Yijun Xu Xue Bai Qi Wang Qi Wang Yujie Huang Yujie Huang |
author_sort |
Yu Mei |
title |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway |
title_short |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway |
title_full |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway |
title_fullStr |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway |
title_full_unstemmed |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway |
title_sort |
fa-97, a new synthetic caffeic acid phenethyl ester derivative, ameliorates dss-induced colitis against oxidative stress by activating nrf2/ho-1 pathway |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2020-01-01 |
description |
Inflammatory bowel disease (IBD) is a chronic idiopathic inflammatory disorder of gastro-intestinal tract, lacking effective drug targets and medications. Caffeic acid phenethyl ester (CAPE), a phenolic constituent derived from propolis, has been reported to be a potential therapeutic agent for IBD with low water solubility and poor bioavailability. In this study, we synthesized a new CAPE derivative (FA-97) and aimed to investigate the effect of FA-97 on DSS-induced colitis. Here, we found that FA-97 attenuated body weight loss, colon length shortening and colonic pathological damage in colitis mice, as well as inhibited inflammatory cell infiltration and expression of pro-inflammatory cytokines in colons. In addition, FA-97 reduced ROS production and MDA generation, while total antioxidant capacity both in DSS-induced colitis mice and LPS-stimulated primary BMDMs and RAW 264.7 cells were enhanced. Mechanically, FA-97 activated Nrf2 followed by increased HO-1 and NQO-1 and down-regulated nuclear levels of p65 and c-Jun, to suppress DSS-induced colonic oxidative stress. Moreover, FA-97 decreased pro-inflammatory cytokine expression and increased the antioxidant defenses in RAW 264.7 via Nrf2 activation. In general, this study reveals that FA-97 activates Nrf2/HO-1 pathway to eventually alleviate DSS-induced colitis against oxidative stress, which has potential activity and may serve as a candidate for IBD therapy. |
topic |
inflammatory bowel disease oxidative stress nuclear factor erythroid 2-related factor (Nrf2) reactive oxygen species (ROS) caffeic acid phenethyl ester (CAPE) |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2019.02969/full |
work_keys_str_mv |
AT yumei fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yumei fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT zihaowang fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT zihaowang fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yifanzhang fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yifanzhang fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT tingwan fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT tingwan fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT jinchengxue fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT jinchengxue fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT weihe fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT weihe fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yiluo fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yiluo fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yijunxu fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yijunxu fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT xuebai fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT qiwang fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT qiwang fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yujiehuang fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway AT yujiehuang fa97anewsyntheticcaffeicacidphenethylesterderivativeamelioratesdssinducedcolitisagainstoxidativestressbyactivatingnrf2ho1pathway |
_version_ |
1725133426767429632 |
spelling |
doaj-786a3dae10644d77bdd04ca7007c01af2020-11-25T01:20:35ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-01-011010.3389/fimmu.2019.02969497023FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 PathwayYu Mei0Yu Mei1Zihao Wang2Zihao Wang3Yifan Zhang4Yifan Zhang5Ting Wan6Ting Wan7Jincheng Xue8Jincheng Xue9Wei He10Wei He11Yi Luo12Yi Luo13Yijun Xu14Yijun Xu15Xue Bai16Qi Wang17Qi Wang18Yujie Huang19Yujie Huang20Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCentre of Clinical Research for Chinese Medicine, School of Chinese Medicine, Institute of Brain and Gut Axis (IBAG), Hong Kong Baptist University, Kowloon Tong, ChinaDepartment of Chemistry, Southern University of Science and Technology, Shenzhen, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaSouthwestern Medical University Affiliated Chinese Medicine Hospital, Quzhou, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInflammatory bowel disease (IBD) is a chronic idiopathic inflammatory disorder of gastro-intestinal tract, lacking effective drug targets and medications. Caffeic acid phenethyl ester (CAPE), a phenolic constituent derived from propolis, has been reported to be a potential therapeutic agent for IBD with low water solubility and poor bioavailability. In this study, we synthesized a new CAPE derivative (FA-97) and aimed to investigate the effect of FA-97 on DSS-induced colitis. Here, we found that FA-97 attenuated body weight loss, colon length shortening and colonic pathological damage in colitis mice, as well as inhibited inflammatory cell infiltration and expression of pro-inflammatory cytokines in colons. In addition, FA-97 reduced ROS production and MDA generation, while total antioxidant capacity both in DSS-induced colitis mice and LPS-stimulated primary BMDMs and RAW 264.7 cells were enhanced. Mechanically, FA-97 activated Nrf2 followed by increased HO-1 and NQO-1 and down-regulated nuclear levels of p65 and c-Jun, to suppress DSS-induced colonic oxidative stress. Moreover, FA-97 decreased pro-inflammatory cytokine expression and increased the antioxidant defenses in RAW 264.7 via Nrf2 activation. In general, this study reveals that FA-97 activates Nrf2/HO-1 pathway to eventually alleviate DSS-induced colitis against oxidative stress, which has potential activity and may serve as a candidate for IBD therapy.https://www.frontiersin.org/article/10.3389/fimmu.2019.02969/fullinflammatory bowel diseaseoxidative stressnuclear factor erythroid 2-related factor (Nrf2)reactive oxygen species (ROS)caffeic acid phenethyl ester (CAPE) |